최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of biomedical engineering research : the official journal of the Korean Society of Medical & Biological Engineering, v.43 no.1, 2022년, pp.19 - 26
유예담 (금오공과대학교 IT융복합공학과) , 정다운 (금오공과대학교 IT융복합공학과) , (금오공과대학교 IT융복합공학과) , 임기무 (금오공과대학교 IT융복합공학과)
The Comprehensive in vitro Proarrhythmic Assay(CiPA) project was launched for solving the hERG assay problem of being classified as high-risk groups even though they are low-risk drugs due to their high sensitivity. CiPA presented a protocol to predict drug toxicity using physiological data calculat...
Fermini B, Fossa AA. "The impact of drug-induced QT interval prolongation on drug discovery and development," Nat. Rev. Drug Discov., 2003;2(6):439-447. doi: 10.1038/nrd1108.
Strauss DG. et al., "Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA Meeting," Ther. Innov. Regul. Sci., 2019;53(4):519-525, doi: 10.1177/2168479018795117.
Fermini B. et al., "A new perspective in the field of cardiac safety testing through the comprehensive in vitro proarrhythmia assay paradigm," J. Biomol. Screen., 2016;21(1):1-11, doi: 10.1177/1087057115594589.
Colatsky T. et al., "The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative - Update on progress," J. Pharmacol. Toxicol. Methods, 2016;81:15-20, doi: 10.1016/j.vascn.2016.06.002.
Dutta S. et al., "Optimization of an in silico cardiac cell model for proarrhythmia risk assessment," Front. Physiol., 2017;8:1-15, doi: 10.3389/fphys.2017.00616.
McMillan B, Gavaghan DJ, Mirams GR. "Early afterdepolarisation tendency as a simulated pro-arrhythmic risk indicator," Toxicol. Res. (Camb)., 2017;6(6):912-921, doi: 10.1039/c7tx00141j.
Mirams GR. et al., "Simulation of multiple ion channel block provides improved prediction of compounds' clinical torsadogenic risk," Cardiovasc. Res., 2011;91(1):53-61, doi: 10.1093/cvr/cvr044.
Llopis-Lorente J, Gomis-Tena J, Cano J, Romero L, Saiz J, Trenor B. "InSilico Classifiers for the Assessment of Drug Proarrhythmicity," J. Chem. Inf. Model., 2020;60(10):5172-5187, doi: 10.1021/acs.jcim.0c00201.
O'Hara T, Virag L, Varro A, Rudy Y. "Simulation of the undiseased human cardiac ventricular action potential: Model formulation and experimental validation," PLoS Comput. Biol., 2011;7(5), doi: 10.1371/journal.pcbi.1002061.
Han X. et al., "A general procedure to select calibration drugs for lab-specific validation and calibration of proarrhythmia risk prediction models: An illustrative example using the CiPA model," J. Pharmacol. Toxicol. Methods, 2020;105:106890, doi: 10.1016/j.vascn.2020.106890.
Crumb WJ, Vicente J, Johannesen L, Strauss DG, "An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel," J. Pharmacol. Toxicol. Methods, 2016;81:251-262, doi: 10.1016/j.vascn.2016.03.009.
Chang KC. et al., "Uncertainty quantification reveals the importance of data variability and experimental design considerations for in silico proarrhythmia risk assessment," Front. Physiol., 2017;8:1-17, doi: 10.3389/fphys.2017.00917.
Parikh J, Di Achille P, Kozloski J, Gurev V. "Global sensitivity analysis of ventricular myocyte model-derived metrics for proarrhythmic risk assessment," Front. Pharmacol., 2019;10:1-18, doi: 10.3389/fphar.2019.01054.
Ahmad K, Dorian P. "Drug-induced QT prolongation and proarrhythmia: an inevitable link?," Europace, 2007;9:4, doi: 10.1093/europace/eum167.
Lancaster MC, Sobie EA. "Improved Prediction of DrugInduced Torsades de Pointes Through Simulations of Dynamics and Machine Learning Algorithms," Clin. Pharmacol. Ther., 2016;100(4):371-379, doi: 10.1002/cpt.367.
Li Z. et al., "Improving the in silico assessment of proarrhythmia risk by combining hERG (Human Ether-a-go-go-Related Gene) channel-drug binding kinetics and multichannel pharmacology," Circ. Arrhythmia Electrophysiol., 2017;10(2):1-12, doi: 10.1161/CIRCEP.116.004628.
Li Z. et al., "Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative," Clin. Pharmacol. Ther., 2019;105(2):466-475, doi: 10.1002/cpt.1184.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.